tradingkey.logo
tradingkey.logo
Search

Azenta Inc

AZTA
Add to Watchlist
16.020USD
-0.780-4.64%
Close 05/15, 16:00ETQuotes delayed by 15 min
738.38MMarket Cap
LossP/E TTM
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-4.64%

5 Days

-16.65%

1 Month

-34.13%

6 Months

-46.15%

Year to Date

-51.83%

1 Year

-41.68%

TradingKey Stock Score of Azenta Inc

Currency: USD Updated: 2026-05-15

Key Insights

Azenta Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 28 out of 382 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 28.50.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Azenta Inc's Score

Industry at a Glance

Industry Ranking
28 / 382
Overall Ranking
124 / 4482
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Azenta Inc Highlights

StrengthsRisks
Azenta, Inc. is a provider of life sciences solutions worldwide. The Company provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The Company's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Company's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The Company's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 593.82M.
Overvalued
The company’s latest PE is -4.25, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 52.28M shares, decreasing 8.52% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 13.35K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.77.

Analyst Rating

Based on 7 analysts
Buy
Current Rating
28.500
Target Price
+69.64%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Azenta Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Azenta Inc Info

Azenta, Inc. is a provider of life sciences solutions worldwide. The Company provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The Company's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Company's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The Company's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
Ticker SymbolAZTA
CompanyAzenta Inc
CEOMarotta (John)
Websitehttps://www.azenta.com/
KeyAI